ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Fulcrum Begins of Losmapimod Trial for Hospitalized COVID-19 Patients
July 03, 2020Fulcrum Therapeutics has received early notification from the U.S. Food and Drug Administration (FDA) that the company may proceed with initiating a Phase 3, randomized, double-blind, placebo-controlled trial of losmapimod in higher risk ... -
Fulcrum Completes IND-enabling Safety Studies for Sickle Cell Disease Treatment
April 14, 2020Fulcrum Therapeutics announced it is on track for submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) in the second half of 2020 for FTX-6058 ...
Pharma Sources Insight January 2025
